GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Using FAP to Selectively Target Epithelial Cancers

$349,435
William W Bachovchin · Tufts University Boston · R01 · FY2015 · CA

Contributions of FGFR-mediated tumor-stromal interactions to breast cancer growth and progression

$349,416
Kathryn L Schwertfeger · University Of Minnesota · R01 · FY2017 · CA

Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapy

$349,406
Sandeep Burma · University Of Texas Hlth Science Center · R01 · FY2022 · CA

Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity

$349,385
David C Linehan · University Of Rochester · R01 · FY2019 · CA

Iron, Ferroptosis and Ovarian Cancer

$349,375
Suzy V Torti · University Of Connecticut Sch Of Med/Dnt · R01 · FY2023 · CA

Stimuli-responsive mucin1-specific nanoparticles for efficacious combinatorial chemotherapy of pancreatic ductal adenocarcinoma

$349,329
Juan Luis Vivero-Escoto · University Of North Carolina Charlotte · R01 · FY2022 · CA

Development of a multifunctional, acoustofluidic 3D bioprinter with single-cell resolution

$349,316
Zhenhua Tian · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · GM

Novel Strategies to Potentiate a Ras-targeted Oncolytic Herpes Simplex Virus

$349,308
Xiaoliu Zhang · University Of Houston · R01 · FY2016 · CA

Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer

$349,262
Iwijn De Vlaminck · Cornell University · R33 · FY2019 · CA

Engineer Biomimetic Microfluidic Models to Investigate and Reprogram Tumor Associated Neutrophils for Cancer Therapy

$349,257
Xiaoping Bao · Purdue University · R37 · FY2025 · CA

Cysteine Protease Network in Tumor Progression and Therapy

$349,249
Roberto G Baccala · Scripps Research Institute, The · R01 · FY2011 · CA

Core D: Digital Pathology and CyTOF

$349,207
Robert A Anders · Johns Hopkins University · P01 · FY2025 · CA

Core D: Digital Pathology and CyTOF

$349,207
Robert A Anders · Johns Hopkins University · P01 · FY2021 · CA

Neuroimmunomodulation within the eye

$349,201
Andrew W Taylor · Boston University Medical Campus · R01 · FY2011 · EY

Environmentally-adaptive nanoparticles with focal irradiation for cancer therapy

$349,200
Yoon Yeo · Purdue University · R01 · FY2017 · EB

Environmentally-adaptive nanoparticles with focal irradiation for cancer therapy

$349,200
Yoon Yeo · Purdue University · R01 · FY2016 · EB

Normalizing PDAC stroma with PCBP2 siRNA nanoparticles to improve the antitumor activity of chemotherapy and immunotherapy

$349,193
Kun Cheng · University Of Missouri Kansas City · R01 · FY2024 · CA

Epigenetically Engineered Mouse Model for Lung Cancer Therapy

$349,064
Lanlan Shen · Baylor College Of Medicine · R01 · FY2022 · CA

MUC13 Mucin in Colorectal Cancer Health Disparity

$349,014
Subhash C. Chauhan · University Of Tennessee Health Sci Ctr · R01 · FY2018 · CA

Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance

$348,993
Aimee L Edinger · University Of California-Irvine · R01 · FY2020 · CA

A preclinical integrated PET/EPR imaging system

$348,969
Chien-Min Kao · University Of Chicago · R01 · FY2020 · EB

Manipulation of Tumor Specific Immunity

$348,950
Hans Schreiber · University Of Chicago · R01 · FY2020 · CA

Tumor cell and microenvironment changes causing antiangiogenic therapy resistance

$348,933
Manish Aghi · University Of California, San Francisco · R01 · FY2018 · NS

Project 1: Targeting Metabolic Vulnerabilities in Lung Cancer

$348,931
Ralph J Deberardinis · Ut Southwestern Medical Center · P50 · FY2020 · CA

Project 1: Optimizing a VSV-based virotherapy-based regimen for advanced MM

$348,913
Martha Q Lacy · Mayo Clinic Arizona · P50 · FY2022 · CA